Torsemide: all 23 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:RecruitingNCT07201584Phase 1
- Optimal Medical Treatment of Difficult-to-treat HypertensionRecruitingNCT06275763Phase 4
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingNCT06218199Phase 4
- Torsemide Comparison With Furosemide for Management of Patients With Stable Heart FailureCompletedNCT05093621Phase 3Results posted
- TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureCompletedNCT03296813Phase 3Results posted
- ToRsemide for pOstpartum HYpertensionCompletedNCT02813551Phase 2Results posted
- Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 DiabetesCompletedNCT01276288Phase 1Results posted
- Bioavailability and Bioequivalence Study of Extended Release Torsemide and SpironolactoneCompletedNCT07046975Phase 3
- Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy SubjectsCompletedNCT07015671Phase 3
- A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 HrsWithdrawnNCT06708611Phase 4
- Pharmacogenetics of Torasemide and Spironolactone in Hypertension TreatmentCompletedNCT06413082Phase 3
- Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting ConditionsCompletedNCT04921566Phase 1
- Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg FurosemideTerminatedNCT03509545Phase 1
- Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in HypertensionCompletedNCT03354897Phase 4
- Weight-Based Torsemide Dosing in Subjects With Heart FailureCompletedNCT03187509Phase 4
- The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves ReplacementCompletedNCT02644616Phase 4
- The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart FailureStatus unknownNCT01942109Phase 4
- Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug PharmacokineticsCompletedNCT01845194Phase 1
- Open Label Study for the Functional Characterization of Drug Metabolism and TransportCompletedNCT01788254Phase 1
- Bioavailability Study of Torsemide Tablets Under Fed ConditionsCompletedNCT00654043Phase 1
- Bioavailability Study of Torsemide Tablets Under Fasting ConditionsCompletedNCT00653549Phase 1
- Bioequivalency Study of Torsemide Tablets Under Fed ConditionsCompletedNCT00602615Not applicable
- Bioequivalency Study of Torsemide Tablets Under Fasting ConditionsCompletedNCT00602303Not applicable